Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 December, 2024 20:17 IST
Chemicals import substitution and China Plus One Strategy to drive volume growth in FY22: Ind-Ra
 

  India Ratings and Research (Ind-Ra) has assigned the chemicals sector an improving outlook for FY22, expecting favourable market conditions across the broad chemical subsectors, along with a healthy rebound in end-user industries, following the COVID-19 led business disruptions in 1HFY21. Ind-Ra expects GDP growth to rebound to 10.4% in FY22 (FY21E: negative 7.8%), and the chemical sector to grow at 1.2x-1.3x of the GDP multiplier.

Chemical sector participants are impacted by a varying degree of end-market demand pressure. Issuers catering to the auto, textiles and construction sectors and in the certain bulk commodities space are expected to witness an extended recovery cycle throughout FY22, whereas those catering to pharma, agrochemicals and personal care are already witnessing a demand surge.

Most companies benefited from stable and lower feedstock prices, even as the prices of final products increased during 2HFY21, supporting margins. India’s push for self-sufficiency coupled with efforts towards supply chain diversification away from China is enabling large capex, which remains a monitorable.

Ind-Ra has a Stable rating Outlook for its rated issuers for FY22, as the agency expects chemical producers to generate strong cash flows from operations, given volume uptick across end-user industries, higher realisations and stable feedstock prices. This would help limit the use of external debt for large capital budgets, as cash flows will be directed towards business expansions, leading to only moderate deterioration in credit metrics during the expansion phase, largely within the rating headroom available for most issuers.

   
© All rights reserved. IRIS Business Services Limited
A Disclaimer